Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

Clinical trial NCT05492409 · COMPLETED

Trial details

NCT number: NCT05492409
Sponsor: AO GENERIUM
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Thrombocytopenic Purpura

Start date: 2022-03-28
Primary completion: 2024-04-03
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.